Page last updated: 2024-08-24

valsartan and Lassitude

valsartan has been researched along with Lassitude in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Ding, XX; Liu, BC; Tang, HX; Wang, B; Wang, GH; Zhang, XL; Zheng, J1
Anand, IS; Deswal, A; Kereiakes, DJ; Purkayastha, D; Zappe, DH1
Benz, JR; Black, HR; Fitzsimmons, S; Graff, A; Reed, A; Shi, Y1

Trials

2 trial(s) available for valsartan and Lassitude

ArticleYear
Comparison of once-daily versus twice-daily dosing of valsartan in patients with chronic stable heart failure.
    Vascular health and risk management, 2010, Aug-09, Volume: 6

    Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Blood Pressure; Creatinine; Cystatin C; Double-Blind Method; Drug Administration Schedule; Fatigue; Female; Glomerular Filtration Rate; Heart Failure; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Potassium; Renin; Tetrazoles; Treatment Outcome; Valine; Valsartan

2010
Valsartan and hydrochlorothiazide in patients with essential hypertension. A multiple dose, double-blind, placebo controlled trial comparing combination therapy with monotherapy.
    Journal of human hypertension, 1998, Volume: 12, Issue:12

    Topics: Adult; Angiotensin II; Antihypertensive Agents; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Fatigue; Female; Headache; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Tetrazoles; Treatment Outcome; Valine; Valsartan

1998

Other Studies

1 other study(ies) available for valsartan and Lassitude

ArticleYear
Effects of Sacubitril/Valsartan on resistant hypertension and myocardial work in hemodialysis patients.
    Journal of clinical hypertension (Greenwich, Conn.), 2022, Volume: 24, Issue:3

    Topics: Adult; Aminobutyrates; Biphenyl Compounds; Double-Blind Method; Drug Combinations; Fatigue; Heart; Humans; Hypertension; Middle Aged; Prospective Studies; Renal Dialysis; Valsartan

2022